期刊文献+

血清骨保护素对非酒精性脂肪性肝炎无创性诊断的价值 被引量:3

Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis
原文传递
导出
摘要 目的 探究骨保护素(OPG)与NAFLD进展的相关性,无创性预测诊断非酒精性脂肪性肝炎(NASH). 方法 筛选136例配套肝穿刺活组织标本及其肝穿刺1周血清标本的非酒精性脂肪肝患者、83例经B型超声检查无脂肪肝症状的正常健康人群作为对照.测量身高、体质量、腰围等生理指标,计算体质量指数;检测丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、AST/ALT、碱性磷酸酶、γ-谷氨酰转移酶、总胆固醇、甘油三酯(TG)、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇等生物化学指标;酶联免疫吸附试验双抗夹心法测定血清中OPG浓度水平.据资料不同采用秩和检验、x2检验、t检验分析、单因素方差分析、Spearman相关分析、LSD检验或受试者工作特征曲线进行统计分析. 结果 血清OPG与AST及TG具有相关性(P<0.05),与肝细胞脂肪变性、气球样变、小叶内炎症、汇管区炎症及纤维化程度呈高度相关(P< 0.01);随NAS评分增高其浓度降低,呈高度负相关(r=-0.928,P<0.01);NASH患者血清中OPG明显低于无NASH患者,经ROC曲线分析,曲线下面积AUROC=0.963,利用Youden指数确定最佳敏感性为96.1%,特异性为97.4%,最佳截断值为242.96 ng/L,具有较高的诊断能力.结论 NASH患者血清OPG水平显著降低,血清OPG可作为评价NASH及其严重程度的独立预测因子,可以作为一个无创性诊断指标对NASH进行诊断. Objective To investigate the correlation of serum osteoprotegerin (OPG) with the progression of nonalcoholic fatty liver disease (NAFLD) and the noninvasive prediction and diagnosis of nonalcoholic steatohepatitis (NASH).Methods A total of 136 patients with NAFLD were enrolled,and their tissue samples for liver biopsy and serum samples obtained at 1 week after liver biopsy were collected;83 healthy subjects without the symptoms of fatty liver disease proved by ultrasound examination were enrolled as controls.The physiological indicators including height,body weight,and waist circumference were measured,and body mass index was calculated.The biochemical parameters including alanine aminotransferase (ALT),aspartate aminotransferase (AST),AST/ALT,alkaline phosphatase,gamma-glutamyl transferase,total cholesterol,triglyceride (TG),high-density lipoprotein cholesterol,and low-density lipoprotein cholesterol were measured.Double-antibody sandwich enzymelinked immunosorbent assay was used to determine the serum level of OPG.The rank sum test,chi-square test,t-test,one-way analysis of variance,Spearman correlation analysis,least significant difference test,and receiver operating characteristic (ROC) curve were applied for statistical analysis of various data.Results Serum OPG level was correlated with AST and TG (P < 0.05),and was highly correlated with hepatocyte fatty degeneration,ballooning degeneration,intralobular inflammation,portal inflammation,and fibrosis degree (P < 0.01).With the increasing NAFLD activity score (NAS),serum OPG level decreased,and there was a highly negative correlation between them (r =-0.928,P < 0.01).Serum OPG level was significantly lower in NASH patients than non-NASH patients.The area under the ROC curve of serum OPG level was 0.963,and according to the Youden index,its optimal sensitivity and specificity were 96.1% and 97.4%,respectively,at an optimal cut-offvalue of 242.96 ng/L,which suggested a high diagnostic power.Conclusion In NASH patients,serum OPG level decreases significantly.Serum OPG level can be used as an independent predictive factor to evaluate NASH and its severity,as well as a noninvasive diagnostic index for NASH.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2016年第2期96-101,共6页 Chinese Journal of Hepatology
基金 首都卫生发展科研专项项目(首发2014-2-5032) 中国肝炎防治基金会王宝恩肝纤维化研究基金(CFHPC20131020) 解放军第三○二医院院长创新基金(YNKT2013041)
关键词 脂肪肝 肝炎 脂肪性 非酒精性 骨保护素 无创诊断 Fatty liver Nonalcoholic steatohepatitis Osteoprotegerin Non-invasive diagnostic
  • 相关文献

参考文献24

  • 1Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States[J]. Am J Gastroenterol, 2003, 98(5): 960-967.
  • 2Kim WR, Brown RS Jr, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop[J]. Hepatology, 2002, 36(1): 227-242.
  • 3Lonardo A, Adinolfi LE, Loria P, et al. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease[J]. Gastroenterology, 2004, 126(2): 586-597.
  • 4Lonardo A, Sookoian S, Chonchol M, et al. Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD[J]. Curr Pharm Des, 2013, 19(29): 5177-5192.
  • 5Musso G, Anty R, Petta S. Anfioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? [J]. Curt Pharm Des, 2013, 19 (29): 5297-5313.
  • 6Ahmed MH, Barakat S, Alrnobarak AO. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? [J]. J Obes, 2012, 2012: 483135. DOI: 10.1155/2012/483135.
  • 7WANG LiDong1, ZHOU Qi1, WEI JunPing1, YANG WanCai1, ZHAO Xin1, WANG LiXia1, ZOU Jian Xiang1, GAO ShanShan1, LI YongXin1 and YANG C.S.2Keywords esophageal neoplasms,apoptosis,precancerous lesions,Waf1 p21 gene,p53.Apoptosis and its relationship with cell proliferation,p53,Waf1p21,bcl-2 and c-mycin esophageal carcinogenesis studied with a high-risk population in northern China[J].World Journal of Gastroenterology,1998,4(4):15-21. 被引量:298
  • 8Farrell GC, Lager CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis[J]. Hepatology, 2006, 43(2 Suppl 1): $99-Sl12.
  • 9Kumar KS, Malet PE Nonalcoholic steatohepatitis[J]. Mayo ClinProc, 2000, 75(7): 733-739.
  • 10Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity[J]. Gastroenterology, 1999, 116(6): 1413-1419.

共引文献574

同被引文献27

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部